|
Q2 2024 Virtual ISPOR Short Course: Leveraging Clinical Outcome Assessment (COA) Data to Maximize the Value of New Treatments Beyond Labeling
Date(s):
June 26 — 27, 2024
Venue:Virtual ISPOR
505 Lawrence Sq Blvd
Lawrenceville, NJ 08648
Website:Not available
Fee(s):This event has a fee
Description:Clinical outcome assessment
(COA) strategies tend to focus on the evidence requirements for FDA/EMA
labeling. Beyond labelling, COA evidence can support the benefit-risk
evaluation and decisions of HTA, clinicians, patients, and policymakers. We
will discuss the value of COA data in the context of patient-focused drug
development and how COA data can be leveraged beyond a typical COA strategy.
...
|
|
|
|
|
|
|
|